PE
TMDX icon

Point72 Europe’s Transmedics TMDX Stock Holding History

Point72 Europe’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-32,100
Closed -$4.83M – 182
2024
Q2 		$4.83M Buy
+32,100
New +$3.85M 0.4% 82

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Point72 Europe's TMDX Position: Q3 2024 in Review

Point72 Europe sold out of Transmedics (TMDX) in Q3 2024, closing a stake of 32,100 shares — an estimated $4.83M sold.

Point72 Europe first reported a position in TMDX in Q2 2024 and held it in 1 quarter. The position peaked at $4.83M in Q2 2024. 373 funds tracked by Wall St. Rank hold TMDX as of Q3 2024.

  • Point72 Europe reported no remaining Transmedics position as of Q3 2024 after selling out during the quarter.
  • Point72 Europe sold 32,100 Transmedics shares in Q3 2024, an estimated $4.83M.
  • Point72 Europe first reported a position in Transmedics in Q2 2024 and held it in 1 quarter.
  • Point72 Europe's Transmedics position peaked at $4.83M in Q2 2024.
  • 373 funds tracked by Wall St. Rank held Transmedics as of Q3 2024.

Based on Point72 Europe's 13F filing for Q3 2024, filed 14 Nov 2024.